Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Related Citations for PubMed (Select 15510091)

1.

Cervical kyphosis is a possible link to attention-deficit/hyperactivity disorder.

Bastecki AV, Harrison DE, Haas JW.

J Manipulative Physiol Ther. 2004 Oct;27(8):e14.

PMID:
15510091
3.
4.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
5.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
7.

Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.

Levin H, Hanten G, Max J, Li X, Swank P, Ewing-Cobbs L, Dennis M, Menefee DS, Schachar R.

J Dev Behav Pediatr. 2007 Apr;28(2):108-18.

PMID:
17435461
8.

Conservative treatment of a patient with syringomyelia using chiropractic biophysics protocols.

Haas JW, Harrison DE, Harrison DD, Bymers B.

J Manipulative Physiol Ther. 2005 Jul-Aug;28(6):452.

PMID:
16096046
9.

National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.

Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, Tzang RF, Wu YY, Huang YF, Chou MC, Liang HY, Hsu YC, Lu HH, Huang YS.

J Clin Psychiatry. 2008 Jan;69(1):131-40.

PMID:
18312048
10.

Conservative treatment of a patient with previously unresponsive whiplash-associated disorders using clinical biomechanics of posture rehabilitation methods.

Ferrantelli JR, Harrison DE, Harrison DD, Stewart D.

J Manipulative Physiol Ther. 2005 Mar-Apr;28(3):e1-8. Erratum in: J Manipulative Physiol Ther. 2005 Jul-Aug;28(6):460.

PMID:
15855899
11.
12.
13.
14.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
15.
16.

Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.

Cohen-Yavin I, Yoran-Hegesh R, Strous RD, Kotler M, Weizman A, Spivak B.

Clin Neuropharmacol. 2009 Jul-Aug;32(4):179-82. doi: 10.1097/WNF.0b013e318183796d.

PMID:
19644227
17.
18.

Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.

Chronis-Tuscano A, Seymour KE, Stein MA, Jones HA, Jiles CD, Rooney ME, Conlon CJ, Efron LA, Wagner SA, Pian J, Robb AS.

J Clin Psychiatry. 2008 Dec;69(12):1938-47. Epub 2008 Dec 2.

PMID:
19192455
19.

Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.

Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A; LYCY Study Group.

Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. doi: 10.1016/j.euroneuro.2009.07.008. Epub 2009 Aug 28.

PMID:
19716683
20.

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

Carpentier PJ, de Jong CA, Dijkstra BA, Verbrugge CA, Krabbe PF.

Addiction. 2005 Dec;100(12):1868-74.

PMID:
16367988
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk